{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:45:51Z","timestamp":1772941551922,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":6409,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>The opioid activity of the amphibian peptide, [Lys<jats:sup>7<\/jats:sup>]dermorphin, was studied in rats and mice. When administered intracerebroventricularly (i.c.v.), intravenously (i.v.) or subcutaneously (s.c.) it produced a long lasting analgesia. Its antinociceptive potency exceeded that of morphine 290 times by i.c.v. injection, and 25\u201330 times by peripheral administration.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The dose\u2010response curves of [Lys<jats:sup>7<\/jats:sup>]dermorphin antinociception were shifted to the right by the pretreatment with naloxone (0.1 mg kg<jats:sup>\u22121<\/jats:sup>, s.c.) or with the \u03bc<jats:sub>1<\/jats:sub>\u2010selective antagonist, naloxonazine (10 mg kg<jats:sup>\u22121<\/jats:sup>, i.v. 24 h before peptide injection).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The peptide also displayed potent antinociceptive effects in a chronic inflammatory pain model (rat Freund's adjuvant arthritis). In this pain model, systemic administration of the peptide raised the nociceptive threshold more in inflamed than in healthy paw.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>High central and peripheral doses of [Lys<jats:sup>7<\/jats:sup>]dermorphin in rats produced catalepsy. The cataleptic response was antagonized by naloxone but left unchanged by naloxonazine pretreatment.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In rats and mice, central or peripheral administration of [Lys<jats:sup>7<\/jats:sup>]dermorphin induced a significantly slower development of tolerance to the antinociceptive effect than did morphine.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Upon naloxone precipitation of the withdrawal syndrome, [Lys<jats:sup>7<\/jats:sup>]dermorphin\u2010dependent mice made fewer jumps and lost less weight than the morphine\u2010dependent animals. Withdrawal hyperalgesia did not develop in [Lys<jats:sup>7<\/jats:sup>]dermorphin\u2010dependent mice.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In conclusion, [Lys<jats:sup>7<\/jats:sup>]dermorphin seems to be a unique opioid peptide having a high penetration into the blood\u2010brain barrier despite its low lipid solubility. This peptide causes fewer side\u2010effects than other opioids and appears less likely than morphine to cause physical dependence in rats and mice.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1995.tb14905.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T00:24:17Z","timestamp":1342743857000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Production of antinociception by peripheral administration of [Lys<sup>7<\/sup>]dermorphin, a naturally occurring peptide with high affinity for \u03bc\u2010opioid receptors"],"prefix":"10.1111","volume":"114","author":[{"given":"Lucia","family":"Negri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Melchiorri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"299","article-title":"Selective blockage of 6\u2010opioid receptors prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"ABDELHAMID E.E.","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_3_1","first-page":"E1","article-title":"Peptide transport systems for opiates across the blood\u2010brain barrier","volume":"259","author":"BANKS W.A.","year":"1990","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(94)90165-1"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(89)90186-X"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(85)90371-7"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(79)90073-X"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1981.tb16797.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90186-2"},{"key":"e_1_2_1_10_1","first-page":"74","article-title":"Method for determining loss of pain sensation","volume":"72","author":"D'AMOUR F.E.","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(85)90361-4"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1965.10480843"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.02-05-00572.1982"},{"key":"e_1_2_1_14_1","first-page":"491","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"JAFFE J.H.","year":"1985"},{"key":"e_1_2_1_15_1","first-page":"502","article-title":"The inhibitory effects of fentanyl and other morphine\u2010like analgesics on the warm water induced tail withdrawal reflex in rats","volume":"13","author":"JANSSEN P.A.J.","year":"1963","journal-title":"Arzneim Forsch."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90319-2"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90333-X"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1523\/JNEUROSCI.14-04-02301.1994","article-title":"Thermal hyperalgesia in association with the development of morphine tolerance in rats \u2013 Roles of excitatory amino acid receptors and protein kinase C","volume":"14","author":"MAO J.","year":"1994","journal-title":"Neurosci. J."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.9.3696"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)80427-I"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb10202.x"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1981.tb01993.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433252"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(79)90204-1"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90021-8"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2846-3_6"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.15.7203"},{"key":"e_1_2_1_28_1","first-page":"544","article-title":"Dermorphin analog Tyr\u2010D\u2010Arg2\u2010Phe\u2010Sarcosine\u2010induced opioid analgesia and respiratory stimulation: the role of ml\u2010receptors","volume":"266","author":"PAAKKARI P.","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-547620-1.50007-2"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.15.7114"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90502-X"},{"key":"e_1_2_1_32_1","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"RANDALL L.O.","year":"1957","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.12.4836"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90223-2"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90376-8"},{"key":"e_1_2_1_36_1","first-page":"654","article-title":"Opioid activities of D\u2010Arg2\u2010substituted tetrapeptides","volume":"242","author":"SATO T.","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90197-5"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90372-3"},{"key":"e_1_2_1_39_1","first-page":"1269","article-title":"Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors","volume":"248","author":"STEIN C.","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_40_1","first-page":"131","volume-title":"Advances in Pain Research and Therapy","author":"STIMMEL B.","year":"1989"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4974-0"},{"key":"e_1_2_1_42_1","first-page":"809","article-title":"Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment","volume":"240","author":"TAO P.L.","year":"1987","journal-title":"J Pharmacol. Exp. Ther."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(75)90251-4"},{"key":"e_1_2_1_44_1","first-page":"86","article-title":"Differential effects of leucine enkephalin and methionine enkephalin on morphine\u2010induced analgesia, acute tolerance and dependence","volume":"208","author":"VAUGHT J.L.","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_45_1","first-page":"1","article-title":"Simultaneous quantitative assessment of morphine tolerance and physical dependence","volume":"167","author":"WAY E.L.","year":"1969","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.16.6393"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1995.tb14905.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1995.tb14905.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:27:00Z","timestamp":1698262020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1995.tb14905.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1476-5381.1995.tb14905.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb14905.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}